Early age of sexual debut: A risky experience

Journal of Family Planning and Reproductive Health Care

Volumn 35, Issue 2, 2009, Pages 118-120

  Stanley, Margaret ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; PROGESTERONE; STEROID HORMONE;

ADOLESCENT PREGNANCY; ARTICLE; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; GENE EXPRESSION; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOLOGY; INFECTION RISK; MALIGNANT TRANSFORMATION; NONHUMAN; PUBLIC HEALTH; RISK ASSESSMENT; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; UNITED KINGDOM; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS ONCOGENE; VIRUS REPLICATION;

ADOLESCENT; ADOLESCENT BEHAVIOR; AGE FACTORS; FEMALE; GREAT BRITAIN; HUMANS; RISK-TAKING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; YOUNG ADULT;

EID: 65249094215     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/147118909787931979     Document Type: Article

References (12)

1. Green J, Berrington de Gonzalez A, Sweetland S, Beral V, Chilvers C, Crossley B, et al. Risk factors for adenocarcinoma and squamous cell carcinoma of the cervix in women aged 20-44 years: the UK National Case-Control Study of Cervical Cancer. Br J Cancer 2003; 89: 2078-2086.
2. Singer A, Jordan JA. The functional anatomy of the cervix, the cervical epithelium and the stroma. In: Jordan JA, Singer A (eds), The Cervix (2nd edn). Oxford. UK: Blackwell Publishing Ltd, 2006; 13-37.
3. Singer A. The cervical epithelium and subepithelium during pregnancy and the puerperium. In: Jordan JA, Singer A (eds), The Cervix (2nd edn). Oxford, UK: Blackwell Publishing Ltd, 2006; 102-121.
4. Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, Choyke PL, et al. Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 2007; 13: 857-861.
5. Remoue F, Jacobs N, Miot V, Boniver J, Delvenne P. High intraepithelial expression of estrogen and progesterone receptors in the transformation zone of the uterine cervix. Am J Obstet Gynecol 2003; 189: 1660-1665.
6. Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 2008; 8: 737-744.
7. Brake T, Lambert PF. Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci USA 2005; 102: 2490-2495.
8. Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003; 89: 88-93.
9. Sasieni P, Castanon A, Parkin DM. How many cervical cancers are prevented by treatment of screen-detected disease in young women? Int J Cancer 2009; 124: 461-464.
10. Sigurdsson K, Sigvaldason H. Is it rational to start population-based cervical cancer screening at or soon after age 20? Analysis of time trends in pre-invasive and invasive diseases. Eur J Cancer 2007; 43: 769-774.
11. Herbert A, Holdsworth G, Kubba A. Cervical screening: why young women should be encouraged to be screened. J Fam Plann Reprod Health Care 2008; 34: 21-25.
12. Wellings K, Nanchahal K, Macdowall W, McManus S, Erens B, Mercer CH, et al. Sexual behaviour in Britain: early heterosexual experience. Lancet 2001; 358: 1843-1850.